The interplay between chemical conjugation and biologic performance in the development of alginate-based 3D matrices to mimic neural microenvironments.


Journal

Carbohydrate polymers
ISSN: 1879-1344
Titre abrégé: Carbohydr Polym
Pays: England
ID NLM: 8307156

Informations de publication

Date de publication:
01 Jan 2024
Historique:
received: 05 07 2023
revised: 09 09 2023
accepted: 16 09 2023
medline: 10 11 2023
pubmed: 9 11 2023
entrez: 8 11 2023
Statut: ppublish

Résumé

Biofunctionalization of polysaccharides is a widely used strategy for obtaining extracellular matrix (ECM)-mimicking biomaterials. Still, commonly employed chemistries present low reaction yields and the selection of the most adequate bioconjugation route can be challenging. Herein, we compared the performance of carbodiimide and reductive amination chemistries for the synthesis of tailored peptide-alginate hybrid hydrogels as neural tissue mimics. Reductive amination dramatically improved the peptide grafting efficiency, with yields of 50 % vs. 20 %, allowing 1.5 to 3-fold higher incorporation of cell-adhesive and matrix-metalloproteinases (MMP)-sensitive peptides, respectively. The conjugation of dual-end reactive MMP-sensitive peptides promoted a partial crosslinking, allowing adjusting gelation, stiffness, and degradability of hydrogels. Such parameters depended on the glycosidic position where the bioactive peptide binds, determined by the adopted chemical strategy, and this significantly impacted the biological response. Reductive amination provided softer (50-210 Pa) and fully degradable (60-100 % weight loss) hydrogels, depending on the amount of peptide in formulation, contrasting with the stiffer (400 Pa) and less degradable (40 % weight loss) carbodiimide-based hydrogels. Due to their opened polymer chain and increased peptide availability to cells, such hydrogels better supported the 3D culture of primary astrocytes, which present high complexity and process branching, allowing the development of improved brain ECM-mimicking systems.

Identifiants

pubmed: 37940293
pii: S0144-8617(23)00877-9
doi: 10.1016/j.carbpol.2023.121412
pii:
doi:

Substances chimiques

Alginates 0
Peptides 0
Hydrogels 0
Carbodiimides 0
Biological Products 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

121412

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Eva D Carvalho (ED)

i3S - Instituto de Inovação e Investigação em Saúde, Universidade do Porto, Porto, Portugal; INEB - Instituto de Engenharia Biomédica, Universidade do Porto, Porto, Portugal; FEUP - Faculdade de Engenharia, Universidade do Porto, Porto, Portugal.

Miguel R G Morais (MRG)

i3S - Instituto de Inovação e Investigação em Saúde, Universidade do Porto, Porto, Portugal; INEB - Instituto de Engenharia Biomédica, Universidade do Porto, Porto, Portugal; ICBAS - Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal.

Ana P Pêgo (AP)

i3S - Instituto de Inovação e Investigação em Saúde, Universidade do Porto, Porto, Portugal; INEB - Instituto de Engenharia Biomédica, Universidade do Porto, Porto, Portugal; ICBAS - Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal. Electronic address: apego@i3s.up.pt.

Cristina C Barrias (CC)

i3S - Instituto de Inovação e Investigação em Saúde, Universidade do Porto, Porto, Portugal; INEB - Instituto de Engenharia Biomédica, Universidade do Porto, Porto, Portugal; ICBAS - Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal. Electronic address: ccbarrias@ineb.up.pt.

Marco Araújo (M)

i3S - Instituto de Inovação e Investigação em Saúde, Universidade do Porto, Porto, Portugal; INEB - Instituto de Engenharia Biomédica, Universidade do Porto, Porto, Portugal. Electronic address: marco.araujo@i3s.up.pt.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH